How to manage primary pulmonary hypertension: Giving hope to patients with a life-threatening illness

Postgraduate Medicine

Volumn 105, Issue 3, 1999, Pages 45-56

  Ricciardi, Mark J ^a   Rubenfire, Melvyn ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANOREXIGENIC AGENT; DEXFENFLURAMINE; PROSTACYCLIN;

ALGORITHM; CLINICAL PRACTICE; CRITICAL ILLNESS; DIAGNOSTIC APPROACH ROUTE; DISEASE COURSE; DISEASE PREDISPOSITION; HEART RIGHT VENTRICLE FAILURE; HUMAN; INCIDENCE; LUNG VENTILATION PERFUSION RATIO; MEDICAL ASSESSMENT; PULMONARY HYPERTENSION; QUALITY OF LIFE; REVIEW;

EID: 0032921907     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1999.03.596     Document Type: Review

References (16)

1. Abenhaim L, Moride Y, Brenot F, et al, for the International Primary Pulmonary Hypertension Study Group. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med 1996;335(9):609-16
2. Connolly HM, Crary JL, McGoon MD, et al. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 1997;337(9):581-8 [Erratum, N Engl J Med 1997;337(24):1783]
3. Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension: a national prospective study. Ann Intern Med 1987;107(2):216-23
4. Kanemoto N, Sasamoto H. Pulmonary hemodynamics in primary pulmonary hypertension. Jpn Heart J 1979;20(4):395-405
5. Eysmann SB, Palevsky HI, Reichek N, et al. Two-dimensional and Doppler-echocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension. Circulation 1989; 80(2):353-60
6. Fuster V, Steele PM, Edwards WD, et al. Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation 1984;70(4):580-7
7. Goodman DJ, Harrison DC, Popp RL. Echocardiographic features of primary pulmonary hypertension. Am J Cardiol 1974; 33(3):438-43
8. Moser KM, Page GT, Ashburn WL, et al. Perfusion lung scans provide a guide to which patients with apparent primary pulmonary hypertension merit angiography. West J Med 1988;148(2):167-70
9. Child JS, Wolfe JD, Tashkin D, et al. Fatal lung scan in a case of pulmonary hypertension due to obliterative pulmonary vascular disease. Chest 1975;67(3):308-10
10. Rubin LJ. Primary pulmonary hypertension. Chest 1993;104(1):236-50
11. Wagenvoort CA, Mulder PG. Thrombotic lesions in primary plexogenic arteriopathy: similar pathogenesis or complication? Chest 1993;103(3):844-9
12. Pietra GG, Edwards WD, Kay JM, et al. Histopathology of primary pulmonary hypertension: a qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry. Circulation 1989; 80(5):1198-206
13. Eisenberg PR, Lucore C, Kaufman L, et al. Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension. Circulation 1990;82(3):841-7
14. Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Mod 1992;327(2): 76-81
15. Barst RJ, Rubin LJ, Long WA, et al, for the Primary Pulmonary Hypertension Study Group. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 1996; 334(5):296-302
16. Pasque MK, Trulock EP, Cooper JD, et al. Single lung transplantation for pulmonary hypertension: single institution experience in 34 patients. Circulation 1995; 92(8):2252-8